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Failure to comply with drug regimes is prevalent amongst patients with epilepsy and the consequence of this is 
often an increased risk of further seizures. This paper describes the level of, and influences upon, non-compliance 
with antiepileptic drug (AED) treatment. A postal questionnaire was sent to an unselected, community-based 
population of patients with epilepsy. This instrument included questions about patients’ AED treatment, any 
related side-effects, and AED-taking behaviour. Univariate analysis showed that factors associated with compliance 
were patient age, how important patients felt it was to take drugs as prescribed, whether patients reported feelings 
of stigma, whether on mono- or polytherapy, whether they were experiencing any side-effects because of AEDs, 
whether patients had a regular arrangement to see their GP about epilepsy and how easy they found their GP to 
talk to. Multivariate analysis showed that the strongest predictors of non-compliance were feeling it was not very or 
not at all important to take AEDs as prescribed, being a teenager, being aged under 60 and being on monotherapy. 
Further implementation of educational programmes for people with epilepsy would help to improve levels of 
compliance thereby reducing the risk of unnecessary seizures. 
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INTRODUCTION 
The sole treatment available for the majority of 
patients with epilepsy is antiepileptic drug (AED) 
therapy’. Research has shown that missing or 
altering antiepileptic drug dosages can have 
adverse reactions, that is, increase the chance of 
seizure recurrence. For instance, Mattson er af* 
report that over one quarter of seizures occurred 
at or before reports of inadequate medication 
levels, and Stanaway et al3 found that over 
one-third (38%) were due to either missed 
medication or inadequate drug levels. Failure to 
follow prescribed drug regimes is known to be 
fairly widespread amongst patients with epilepsy: 
research has shown that between 25 and 75% fail 
to adhere”‘, in particular very young or very old 
patients”, and teenagers”. Given that failing to 
comply may increase the likelihood of hospital 
admission”, there could be a potential saving to 
the National Health Service if compliance could 
be improved. 
The use of the term ‘compliance’ in relation to 
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health care became commonplace amongst physi- 
cians during the late 197Os, and it was then that it 
came to be recognized as a vital factor in the 
assessment of treatments”. The definition of 
compliance/non-compliance is not straightfor- 
ward, however. Ley ‘* lists among its aspects not 
taking the correct dosage (too much or too little), 
failing to leave the recommended length of time 
between doses, not taking medication for the 
duration specified, taking other drugs not 
prescribed. 
Some commentators believe that any patient 
who fails to adhere on one occasion or more is 
non-compliant whereas others feel that only those 
who fail to comply more than occasionally, say at 
least 25% of the time, should be classed as 
non-compliant’*. 
Just as the definition of compliance is prob- 
lematic, so too is its measurement. Various 
methods used include patients’ reports, pill 
counts, blood tests, outcome (i.e. shifts in 
behaviour or changes in the condition) and 
doctors’ estimations-the latter is commonly 
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believed to be the least valid method’*. The 
method of counting pills in order to verify 
whether or not the correct number have been 
used up has also been widely criticized-patients 
have been known to empty out pills without 
actually taking them. A recently-developed elec- 
tronic device which records the date and time on 
each opening of the bottle13 has been heralded as 
a significant advance in the measurement of 
compliance-but even with such sophisticated 
methods there can be no guarantee that pills are 
actually taken unless a physician or researcher 
stands guard over each individual patient every 
time their doses are due. 
The term ‘compliance’ has been frowned upon 
because it has connotations of subservience. 
Stockwell Morris and Schulz14 argue that the term 
non-compliance implies deviance and so is 
inappropriate, since patients’ decisions result 
from a reasoned attempt to balance not only 
clinical but also social, psychological and other 
factors. Although some have suggested ‘non- 
adherence’ as an alternative, less negative term 
others argue that there appears to be no other 
single word more suitable”. We have opted to 
refer to ‘compliance’ and ‘non-compliance’ thro- 
ughout this paper, simply because they seem to be 
the most commonly-used expressions. 
Although the bulk of the literature on com- 
pliance grew out of a concern with clinical 
outcomes, some studies with a wider focus have 
examined personal and other non-clinical 
outcomes’“. 
According to Stockwell Morris and Schulz’4, 
non-compliance is usually intentional and ra- 
tional, in that patients assess the effects of their 
medication on their everyday life generally and 
the side-effects on their social functioning specifi- 
cally. Pryse-Phillips, et a/l5 argue that to regard 
compliance as merely a patient’s ability to comply 
with a drug regime exactly as instructed is too 
simplistic and they define it instead as ‘an 
inclination or readiness to yield to the demands of 
others’. They also suggest that there are two types 
of compliance: firstly, compliance is simply the 
‘regular ingestion of medication as and when 
prescribed’; secondly, compliant (or insightful) 
behaviour is that where patients have an active 
and informed part to play in a therapeutic 
situation. This sort of insightful behaviour (e.g. 
reducing one’s dosage because of a particular 
side-effect and subsequently improving outcome) 
was displayed by 20% of the patients in 
Pryse-Phillips et al’s study. Schneider and 
ConradI also identified patients who exhibited 
‘compliant behaviour’ and defined these as 
‘self-regulators’. According to Pryse-Phillips er 
al”, this sort of behaviour may be just as vital to 
condition-management as the traditionally- 
defined form of compliance. 
Research has shown that there are several 
factors which hinder compliance. Although for- 
getfulness plays a large part, together with 
confusing advice and fear of dependence or 
side-effects4, factors such as doubting the diag- 
nosis, uncertainty about the necessity for drugs 
and anxiety over the complexity of the drug 
regimen also contribute’. Another influential 
factor is patients’ perceptions of their physician: 
Freeman et al” found that patients were more 
likely to take their medication as required when 
they perceived their physicians as being easy to 
talk to. Ley and Morris” found providing patients 
with written information resulted in better 
adherence rates; though numerous studies have 
shown that informing patients has no effect14.“. 
The present paper reports on the degree to 
which a sample of adult patients with epilepsy 
missed taking their AEDs and examines various 
factors associated with this non-compliance. 
STUDY DESIGN AND METHODS 
The data reported here are derived from a 
community-based study of epilepsy undertaken in 
1993 in one UK health region. Individuals with a 
history of seizures during the previous two years, 
or seizure-free in that time but taking AED 
medication, were defined as eligible for the study. 
They were identified from the records of 31 
general practices, selection of the practices being 
stratified by health district and practice size. 
Study methods have been described in detail 
elsewhere”. Nine hundred and seventy-five sub- 
jects aged 16 or over were sent a postal 
questionnaire and 769 were returned of which 40 
were rejected as unusable (more than 10% of 
relevant questions had been unanswered) and a 
further 33 because they had been completed by a 
proxy informant. Thus, 696 usable questionnaires 
were available for analysis (a response rate of 
71%). 
The postal questionnaire included questions 
about the clinical nature and history of subjects’ 
epilepsy, demographic details and medical care 
(general practitioner and hospital clinic). It also 
included a previously validated seizure severity 
scale2’, comprising two sub-scales related to 
patients’ perception of control (such as the timing 
of the seizures, whether or not the patient could 
predict them) and ictal and post-ictal effects (such 
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as loss of consciousness or post-ictal confusion). 
Measures of psychosocial functioning included: 
the hospital anxiety and depression scale 
(HAD)“; the impact of epilepsy scale**; the life 
fulfilment scale23; and the stigma of epilepsy 
scale”. Information was sought about current 
AED therapy, how well patients felt the drugs 
controlled their attacks, whether or not they 
believed it was important to take drugs as 
prescribed, and side-effects of drugs using a 
recently developed adverse events profile=. 
Drug-taking behaviour was examined by asking 
patients whether and how regularly they missed 
taking their AEDs. This was the only measure of 
compliance used in the present study, and is the 
method used most often in research’*. 
The SPSSx statistical package for social 
sciences26 was used to analyse the data. Univari- 
ate analysis consisted of contingency table analy- 
sis, with differences using chi squared tests 
reported at the 5% and 1% level: differences in 
proportion and 95% confidence intervals (CIs)*’ 
are also reported. Multivariate analysis employed 
logistic regression, where the dependent variable 
was whether or not patients complied with their 
AED therapy regimes: odds ratios are also 
reported. 
RESULTS 
Out of 696 patients, 95% were taking AEDs 
(68% were on one type of drug only, i.e. 
monotherapy, and 27% were on polytherapy). Of 
these 95%, almost three-quarters (72%) of 
patients said they never missed taking their 
AEDs, 15% missed less than once a month, 9% 
missed more than once a month but less than 
weekly and 4% missed at least once a week. 
Patients were asked how well they felt AEDs 
controlled their attacks: 61% said they were very 
well controlled, 32% said fairly well, 6% said not 
very well and 1% said not at all. Fifty per cent of 
patients taking AEDs reported experiencing 
AED side-effects, the most commonly reported 
being related to the central nervous system: 
tiredness (80% of those on AEDs), memory 
problems (71%) concentration (63%) sleepiness 
(63%) depression (60%) and headaches (58%). 
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Given that the number of patients who said they 
missed taking their AEDs at least once a week 
was so low (n = 31), the ‘frequency missed’ 
variable was collapsed into three categories: 
never missed, missed less than once a month and 
missed once a month or more, for the purpose of 
univariate analyses. 
Patient characteristics 
Table 1 shows that patients’ age was significantly 
associated with whether or not they missed taking 
their tablets, with younger patients (i.e. those 
under 60) being less likely than older ones to 
always comply (66% and 86%, respectively, 
difference in proportions 20, 95% CIs 13-27). 
Furthermore, teenagers were less likely than 
others to always comply (52% compared with 
72% of those aged over 19, difference in 
proportions 20, 95% CIs l-39), and were more 
likely to miss infrequently (though there were no 
differences between teenagers and others in the 
percentages missing often). Social class (x2 = 
4.85, P = 0.09) and gender of patient k* = 1.74, 
P = 0.04) were not significantly related to likeli- 
hood of missing medication. 
Not surprisingly, patients who felt that it was 
very important to take their tablets as prescribed 
were the group most likely to comply-76% 
always complied compared with 29% of those 
who felt it was only fairly or not at all important 
(difference in proportions 49, 95% CIs 38-60). 
There was a significant relationship between 
whether or not patients reported feeling stig- 
matized by their epilepsy and likelihood of 
compliance, with only 66% of those who felt 
stigmatized saying that they always complied 
compared with 74% of those who did not feel 
stigmatized (difference in proportions 8,95% CIs 
1-15). 
Clinical characteristics 
There was no relationship between whether or 
not patients missed taking their tablets and 
seizure frequency (x2 = 2.79, P = 0.6), seizure 
type h’= 4.68, P = 0.3) whether patients felt 
their attacks were well-controlled (x2 = 3.19, 
P = 0.2) seizure severity (ICTAL P = 0.05, odds 
ratio 0.1; PERCEPT P = 0.8, odds ratio O.l)*, 
length of time seizure-free (P = 0.5, odds ratio 
0.2) or duration of epilepsy (P = 0.07, odds ratio 
‘The relationship between compliance and continuous 
variables such as seizure severity and duration of epilepsy 
were each examined using logistic regression techniques. 
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Table 1: Factors affecting compliance with AED regimes 
Frequency miss taking AEDs: 
Never <once a month at least once a month 
% % % 
Age: 
Under 60 (n = 460) 66 18 17 x2 = 26.14 
60 or over (n = 180) 86 8 6 P < O.ooool 
Teenager (n = 25) 52 32 16 x2 = 6.66 
Over 20 (n = 615) 72 14 14 P < 0.05 
How important to take drugs 
as prescribed: 
Very important (n = 597) 76 15 9 x2 = 100.50 
Fairly/not at all P<O.ooool 
important ()I= 64) 29 17 53 
Reported feelings of stigma: 
Yes (n = 245) 66 19 15 x2 = 6.82 
No (n = 394) 74 I3 13 P < 0.05 
No. of drugs 
Monotherapy (11 = 467) 68 I7 15 x2 = 13.61 
Polytherapy 01 = 190) 82 9 9 P<O.Ol 
Side-effects due to AEDs: 
Yes (n = 326) 67 I8 I6 x2 = 9.6 
No (/I = 328) 77 I2 11 PCO.01 
How perceive general 
practilioner: 
Easy to talk 10 (n = 394) 73 I4 14 x2 = 6.58 
Not easy (n = 63) 57 24 19 P < 0.05 
Have regular arrangement 
IO see GP about epilepsy: 
Yes (n = 69) 81 19* x2 = 4.61 
No (n = 382) 68 32 P < 0.05 
* Although there was no significant difference between never missing, missing less than once a month or missing at least once a 
month and having a regular arrangement to see GP, the difference was significant when the ‘frequency missed’ variable was 
collapsed into two categories: whether missed at all or never missed. 
0.2). Patients on monotherapy were less likely 
than those on polytherapy to always comply with 
their medication (68% and 82%, respectively, 
difference in proportions 14, 95% CIs 7-21). 
Patients who reported experiencing side-effects 
because of their AEDs were somewhat less likely 
to comply than those who did not (67% and 77%, 
difference in proportions 10, 95% CIs 3-17). 
Although compliance levels were not directly 
related to seizure frequency, patients on mo- 
notherapy had less frequent seizures than others, 
with 22% of those on just one type of drug having 
seizures at least once a month compared with 
33% of patients on more than one type (x2 = 
9.70; P ~0.01). Also, patients on monotherapy 
reported a significantly shorter duration of 
epilepsy than those on polytherapy (49% had had 
epilepsy for at least ten years compared with 77% 
of those on polytherapy, x2 = 49.45; P < O.OOOOl), 
were less likely to report experiencing side-effects 
(46% compared with 59%, x2 = 8.11; P < 0.01) 
and were more likely to consider their attacks 
well-controlled (95% compared with 87%, x2 = 
10.92; P < 0.001). 
Physician characteristics 
Despite some evidence indicating that informa- 
tion provision increases compliance*“, no re- 
lationship was found between amount of infor- 
mation received from the GP (x2 = 2.54, P = 0.3) 
or clinic doctor 01’ = 1.72, P = 0.4) and levels of 
compliance. However, feeling that the doctor was 
easy to talk to was important, at least in relation 
to GPs; of those who found their GP easy to talk 
to, 73% always complied compared with only 
57% of patients who did not find their GP easy to 
talk to (Table 1, difference in proportions 16, 
95% CIs 3-29). There was no association 
between how easy the hospital clinic doctors were 
to talk to and level of compliance &* = 1.15, 
P = 0.6). 
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Having a regular arrangement to see the GP 
about epilepsy was significantly related to 
whether patients missed taking drugs or not: 
those who did have such an arrangement were 
less likely to miss than those who did not (19% 
compared with 32%, difference in proportions 13, 
95% CIs 3-23). There was no significant relation- 
ship between compliance and the number of 
times patients had seen their GP (P = 0.2, odds 
ratio 0.2) or clinic doctor (P = 0.05, odds ratio 
0.1) in last year. 
A logistic regression whereby all clinical and 
other patient characteristics were included in the 
model (Table 2) showed that the best predictors 
of missing AEDs were: feeling it is not very or not 
at all important to take AEDs as prescribed, 
being a teenager (i.e. 16-19), being aged under 
60, being on monotherapy. 
DISCUSSION 
The nature of the present study and the methods 
of data collection employed precluded the pos- 
sibility of any pill counting procedures or blood 
level testing, and information about compliance 
was therefore limited to patients’ own accounts. 
However, Ley” notes that studies of correlations 
between patients’ reports and mechanical meth- 
ods indicate a mean correlation of +0.80, and 
results from patients’ reports will generally be 
akin to those of other methods. Despite this 
Table 2: Explanatory clinical variables included in the 
model and variables predicting missing AEDs 
Included in the model: 
Whether on monotherapy or polytherapy 
Seizure frequency 
Seizure type 
Duration of epilepsy 
Seizure severity 
Whether or not have any side-effects due to AEDs 
Number of side-effects 
Whether or not feel attacks are well-controlled by AEDs 
How important feel it is to take AEDs as prescribed 
Whether feel stigmatised because of epilepsy 
Gender 
Social class 
Whether aged under 60 or 60+ 
Whether a teenager (i.e. 16-19 years old) 
Predicting variables: 
Feel it is not very or 
unimportant to take 
AEDs as prescribed 
Teenager 
Aged under 60 
Beine on monotheraov 
P< odds ratio 
0.0001 15.6 
0.05 5.4 
0.02 3.2 
0.03 2.2 
possible limitation, our findings verify much 
previous research into the issue of compliance, 
and contribute to our knowledge of the drug- 
taking behaviour of adults with epilepsy. 
Previous studies indicate that non-compliance 
with AED therapy is fairly evenly spread 
throughout social classes and between gender’ 
and in this study also, no significant differences 
were found between either social class or gender 
and levels of compliance. Age, however, has been 
shown to be important. In particular, failure to 
comply with AED therapy is common amongst 
young people29; Takaki et af9 found that teen- 
agers were the most erratic in terms of complying. 
In the present study, too, although the numbers 
of teenagers was small, they were significantly 
more likely than others to miss taking their 
AEDs. Clearly, on top of the general problems 
faced by any teenager, the effects of being in 
some way ‘different’, because of having a 
condition which peers do not comprehend, can 
lead to a denial of the presence of the condition 
manifested by non-compliance with drug regimes; 
equally, for some teenagers non-compliance may 
be attributable to the lack of a clear understand- 
ing of why it is important both to take AEDs and 
to take them precisely as prescribed2’. 
There were no significant differences between 
whether or not patients missed taking drugs and 
some basic clinical characteristics, namely seizure 
type, seizure severity, duration of epilepsy, length 
of time seizure-free and, perhaps surprisingly, 
seizure frequency. We did find that patients on 
polytherapy were more likely to comply than 
those on monotherapy and other studies have had 
similar results? this could be due to the fact that 
patients on polytherapy have a history of more 
frequent seizures whatever their current seizure 
activity, and so come to feel it is more important 
to comply with their medication regime. It was 
also the case that subjects who reported ex- 
periencing any AED side-effects were more likely 
to be non-compliant, a finding which corresponds 
to that reported in the Veterans’ Administration 
Study2. It may be that the nature of side-effects 
associated with AEDs-often central nervous 
system-related-increases the likelihood of non- 
compliance because such side-effects are more 
obtrusive on psychosocial functioning than those 
of other drugs. 
A review of studies on the importance of 
written information’8 suggests that information 
provision leads to greater levels of compliance. It 
has been argued, however, that ability to comply 
with a medication regime depends not only on 
understanding and following doctors’ orders but 
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also, and perhaps more importantly, on how these 
fit into patients’ lives3’-a sound understanding of 
information is no guarantee of compliance. In the 
present study, univariate analysis showed that 
satisfaction with the amount of information given 
by GP or clinic doctor had no effect on the 
likelihood of missing taking AEDs, but that 
patients who thought it was unimportant to take 
medication as prescribed were less likely to 
comply: this could reflect the possibility that they 
were making a decision based on their lifestyle 
and personal experience, rather than simply 
following doctor’s orders blindly. Patients may 
well have been displaying the sort of ‘insightful 
behaviour’ which Pryse-Phillips et al I5 described 
and which is reported in a number of studies of 
patients with epilepsy. Scambler and Hopkins3’, 
for example, found that some patients took it 
upon themselves to alter their drug-taking be- 
haviour because of adverse side-effects, fear of 
addiction or a general dissatisfaction with treat- 
ment and Conrad32 found that patients with 
epilepsy would test whether or not they still had 
the condition by decreasing or ceasing to take 
prescribed drugs. However, an alternative ex- 
planation is that information, particularly regard- 
ing the issue of the importance of compliance, 
may not have been sufficiently targeted. 
Another potential contributing factor in non- 
compliance may be the patient’s perception of the 
doctor’4: if the doctor is viewed as concerned, and 
prescribing of medication as a reflection of that 
concern, then compliance may be higher than if 
the prescription is seen as an indication that the 
doctor has no time for or interest in the patient. 
In the present study a significant relationship was 
found between how easy patients found their GPs 
to talk to and levels of reported compliance, with 
those feeling they were not easy to talk to being 
less likely to comply than those who felt they 
were. Similar findings are reported in earlier 
research”. 
The amount of contact that patients have with 
their physicians may also be an influential factor. 
Wannamaker et aP3 discovered that patients who 
saw their doctors most often were most likely to 
comply. Although in the present study there was 
no significant relationship between compliance 
and the number of times patients saw their GP or 
clinic doctor during the previous year, those 
patients who had a regular arrangement to see 
their GP specifically about epilepsy were more 
likely to comply; this may well reflect the 
possibility that regular contact with a clinician 
offered an opportunity to discuss any problems 
arising over drug-taking and to emphasize the 
importance of good compliance in the control of 
seizures. 
Scambler and Hopkins3’ emphasize that many 
patients are not passive, but play an active part in 
managing their own condition, and at times this 
will be in conflict with the advice of their doctor. 
Of particular concern to some patients is the 
stigma associated with having epilepsy: if con- 
tinued therapy is seen as implying continued 
epilepsy then, it has been argued, by reducing or 
missing their AEDs some patients are seeking to 
renegotiate an undesirable labe13’.32. In the 
present study, patients who reported feelings of 
stigma associated with their condition were more 
likely than others to miss taking their AEDs. 
This study has highlighted a number of reasons 
why patients may not comply with their medica- 
tion regimes, and a key predictor of non- 
compliance was feeling that it was not very or not 
at all important to take AEDs as prescribed. One 
possible way to encourage compliance is through 
specific educational programmes such as those 
developed by Helgeson and Mittan” for epilepsy 
and by Bailey et aP4 for asthma. 
Implementation of such programmes for 
people with epilepsy, which acknowledge the 
rational basis for non-compliance and the factors 
influencing it, would perhaps help to improve 
levels of compliance and so reduce the risk of 
unnecessary seizures, as would specific prog- 
rammes for teenagers which would need to take 
into account the particular impact that epilepsy 
has on their self-perception and behaviour and 
equip them with sufficient knowledge about their 
condition and the treatment they receive for it. 
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